DK148344C - Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof - Google Patents

Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof

Info

Publication number
DK148344C
DK148344C DK113676A DK113676A DK148344C DK 148344 C DK148344 C DK 148344C DK 113676 A DK113676 A DK 113676A DK 113676 A DK113676 A DK 113676A DK 148344 C DK148344 C DK 148344C
Authority
DK
Denmark
Prior art keywords
preparation
procedure
active substance
extended release
pharmaceutical preparation
Prior art date
Application number
DK113676A
Other languages
Danish (da)
English (en)
Other versions
DK148344B (da
DK113676A (da
Inventor
Prabhakar Ranchhordas Sheth
Jacques Levon Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of DK113676A publication Critical patent/DK113676A/da
Publication of DK148344B publication Critical patent/DK148344B/da
Application granted granted Critical
Publication of DK148344C publication Critical patent/DK148344C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK113676A 1975-03-17 1976-03-16 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof DK148344C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US55910775 1975-03-17
US65800376A 1976-02-13 1976-02-13
US65800376 1976-02-13
KR760000645 1976-03-16
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (3)

Publication Number Publication Date
DK113676A DK113676A (da) 1976-09-18
DK148344B DK148344B (da) 1985-06-17
DK148344C true DK148344C (da) 1985-11-04

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
DK113676A DK148344C (da) 1975-03-17 1976-03-16 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof

Country Status (21)

Country Link
JP (1) JPS51115910A (enrdf_load_html_response)
AR (1) AR222624A1 (enrdf_load_html_response)
AT (1) AT353415B (enrdf_load_html_response)
AU (1) AU505355B2 (enrdf_load_html_response)
CA (1) CA1073358A (enrdf_load_html_response)
CH (1) CH630257A5 (enrdf_load_html_response)
DD (1) DD124102A5 (enrdf_load_html_response)
DE (1) DE2611041A1 (enrdf_load_html_response)
DK (1) DK148344C (enrdf_load_html_response)
ES (1) ES446075A1 (enrdf_load_html_response)
FR (1) FR2304354A1 (enrdf_load_html_response)
GB (1) GB1546448A (enrdf_load_html_response)
GR (1) GR60341B (enrdf_load_html_response)
IE (1) IE43083B1 (enrdf_load_html_response)
LU (1) LU74558A1 (enrdf_load_html_response)
MC (1) MC1101A1 (enrdf_load_html_response)
NL (1) NL190313C (enrdf_load_html_response)
NZ (1) NZ180321A (enrdf_load_html_response)
PH (1) PH14927A (enrdf_load_html_response)
PT (1) PT64907B (enrdf_load_html_response)
SE (1) SE433804B (enrdf_load_html_response)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE69207656T2 (de) * 1991-01-30 1996-10-17 The Wellcome Foundation Ltd., London Wasserlösliche tabletten
AU1560692A (en) * 1991-04-08 1992-11-02 Nippon Shinyaku Co. Ltd. Capsule
JPH07507059A (ja) * 1992-03-25 1995-08-03 デポムド　システムズ，インコーポレイテッド アルキル置換セルロースをベースとする持続放出性経口薬剤投与剤形
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
CA2175225C (en) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Gelatin capsule fill able to foam
CN1133558A (zh) * 1993-10-29 1996-10-16 雷克特和科尔曼产品有限公司 可发泡的明胶胶囊填充药物
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
CA2190188A1 (en) * 1994-05-13 1995-11-23 Prasad S. Adusumilli Method and composition for increasing calcium uptake
CN1172429A (zh) * 1994-12-01 1998-02-04 希博斯药物公司 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (enrdf_load_html_response) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
AU505355B2 (en) 1979-11-15
PT64907B (fr) 1978-03-24
CH630257A5 (en) 1982-06-15
NZ180321A (en) 1978-06-20
SE7603325L (sv) 1976-09-18
ES446075A1 (es) 1977-09-16
AT353415B (de) 1979-11-12
GR60341B (en) 1978-05-17
MC1101A1 (fr) 1977-02-04
DD124102A5 (enrdf_load_html_response) 1977-02-02
FR2304354B1 (enrdf_load_html_response) 1979-04-27
PH14927A (en) 1982-01-29
CA1073358A (en) 1980-03-11
LU74558A1 (enrdf_load_html_response) 1977-09-27
NL190313B (nl) 1993-08-16
NL190313C (nl) 1994-01-17
DE2611041A1 (de) 1976-10-14
JPS638084B2 (enrdf_load_html_response) 1988-02-19
IE43083L (en) 1976-09-17
DK148344B (da) 1985-06-17
JPS51115910A (en) 1976-10-13
IE43083B1 (en) 1980-12-17
DE2611041C2 (enrdf_load_html_response) 1988-06-09
NL7602776A (nl) 1976-09-21
AR222624A1 (es) 1981-06-15
FR2304354A1 (fr) 1976-10-15
GB1546448A (en) 1979-05-23
ATA192276A (de) 1979-04-15
SE433804B (sv) 1984-06-18
PT64907A (fr) 1976-04-01
AU1204976A (en) 1977-09-22
DK113676A (da) 1976-09-18

Similar Documents

Publication Publication Date Title
DK148344C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof
DK513476A (da) Fremgangsmade til fremstilling af preparater med kontrolleret afgivelse af en virksom bestanddel
DK153773C (da) Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel
DK371277A (da) Fremgangsmaade til fremstilling af farmaceutiske doseringsformer med vedvarende virkning
DK567376A (da) Fremgangsmade til fremstilling af quinazolonderivater
DK48276A (da) Fremgangsmade til fremstilling af isoxazolylbenzamidderivater
DK562276A (da) Fremgangsmaade til fremstilling af en farmaceutisk administrationsform
DK431979A (da) Fremgangsmaade til fremstilling af et stof med bakteriosttisk virkning
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK298476A (da) Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK523277A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
DK55376A (da) Fremgangsmade til fremstilling af beta-dihalogenethenylcyclopropanderivater
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK497476A (da) Fremgangsmade til fremstilling af et antibiotisk stof
DK565676A (da) Fremgangsmade til fremstilling af klavamderivater
DK142990C (da) Fremgangsmaade til fremstilling af antibakterielt virksomme aldehydderivater af clavulansyre
DK529278A (da) Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK343976A (da) Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
DK211277A (da) Fremgangsmade til fremstilling af isothiourinstofderivater
DK242078A (da) Fremgangsmaade til fremstilling af et antidepressivt virksomt pharmaceutisk praeparat

Legal Events

Date Code Title Description
PUP Patent expired